David L. Porter, MD discusses the treatment algorithims in use at Penn Medicine and the Abramson Cancer Center to minimize the effects of graft-versus-host disease, one of the severe and debilitating effects of chemotherapy in patients with hematological cancers.
Published
August 14, 2014
Created by
BROADCASTMED